Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity. (4th August 2022)
- Record Type:
- Journal Article
- Title:
- Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity. (4th August 2022)
- Main Title:
- Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity
- Authors:
- Alwafi, Hanadi Abdullah
Ali, Soad Shaker
Kotha, Sunil Babu
Abuljadayel, Layla Waleed
Ibrahim, Maha
Elahi, Ibrahim Rashad Noor
Alwafi, Hebah Abdullah
Almuhayawi, Mohammed S.
Finkelman, Matthew D.
El-Shitany, Nagla A. - Other Names:
- Stantchev Tzanko Academic Editor.
- Abstract:
- Abstract : High levels of inflammatory cytokines in serum have been reported in patients with severe SARS-CoV-2 infection. There is growing interest in recognizing the role of inflammatory biomarkers in saliva in diagnosing systemic diseases. This study assumed that estimating biomarkers in saliva samples from patients infected with SARS-CoV-2 would distinguish between mild and severe cases. Saliva was collected from 142 controls and 158 SARS-CoV-2 patients (mild 72 and severe 86) to measure interleukin-6 (IL-6), C-reactive protein (CRP), and C-X-C motif chemokine ligand-10 (CXCL-10). IL-6 and CXCL-10 were significantly increased in patients with mild and severe SARS-CoV-2 infections. CRP was significantly increased only in severe SARS-CoV-2 cases. All biomarkers were significantly higher in severe cases than in mild cases (p < 0.001 ). Among patients with SARS-CoV-2 infection, men showed significantly higher CRP and CXCL-10 levels than females (p < 0.01 and 0.05, respectively). In addition, elderly patients (40–80 years) had significantly higher IL-6, CRP, and CXCL-10 (p < 0.001 ). Patients with diabetes and hypertension showed elevated IL-6, CRP, and CXCL-10 (p < 0.001 ). There was a significant positive correlation between IL-6, CRP, CXCL-10, and between age, IL-6, CRP, and CXCL-10. Saliva may have a future value in measuring the inflammatory biomarkers associated with the severity of SARS-CoV2 infection and therapeutic monitoring.
- Is Part Of:
- Canadian journal of infectious diseases & medical microbiology =. Volume 2022(2022)
- Journal:
- Canadian journal of infectious diseases & medical microbiology =
- Issue:
- Volume 2022(2022)
- Issue Display:
- Volume 2022, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 2022
- Issue:
- 2022
- Issue Sort Value:
- 2022-2022-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-08-04
- Subjects:
- Communicable diseases -- Periodicals
Infection -- Periodicals
Communicable diseases
Infection
Communicable Diseases
Communicable Disease Control
Electronic journals
Periodicals
Fulltext
Internet Resources
Periodicals
616.9 - Journal URLs:
- https://www.hindawi.com/journals/cjidmm/ ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/460/ ↗
http://search.proquest.com/publication/2032235 ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/460/ ↗
https://www.ncbi.nlm.nih.gov/pmc/journals/460/ ↗ - DOI:
- 10.1155/2022/1543918 ↗
- Languages:
- English
- ISSNs:
- 1712-9532
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 23048.xml